Showing 1 - 3 results of 3 for search 'Mikko Haapio', query time: 0.01s Refine Results
  1. 1
    Gemtuzumab-Ozogamicin-Related Impaired Hemoglobin-Haptoglobin Scavenging as On-Target/Off-Tumor Toxicity of Anti-CD33 AML Therapy: A Report of Two Cases

    Gemtuzumab-Ozogamicin-Related Impaired Hemoglobin-Haptoglobin Scavenging as On-Target/Off-Tumor Toxicity of Anti-CD33 AML Therapy: A Report of Two Cases by Hanna L. M. Rajala, Veli-Jukka Anttila, Mikko Haapio, Mikko A. I. Keränen, Ulla Wartiovaara-Kautto, Riikka Räty

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Volume Assessment in Mechanically Ventilated Critical Care Patients Using Bioimpedance Vectorial Analysis, Brain Natriuretic Peptide, and Central Venous Pressure

    Volume Assessment in Mechanically Ventilated Critical Care Patients Using Bioimpedance Vectorial Analysis, Brain Natriuretic Peptide, and Central Venous Pressure by Andrew A. House, Mikko Haapio, Paolo Lentini, Ilona Bobek, Massimo de Cal, Dinna N. Cruz, Grazia M. Virzì, Rizzieri Carraro, Giampiero Gallo, Pasquale Piccinni, Claudio Ronco

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    B-Type Natriuretic Peptide in the Critically Ill with Acute Kidney Injury

    B-Type Natriuretic Peptide in the Critically Ill with Acute Kidney Injury by Massimo de Cal, Mikko Haapio, Dinna N. Cruz, Paolo Lentini, Andrew A. House, Ilona Bobek, Grazia M. Virzì, Valentina Corradi, Flavio Basso, Pasquale Piccinni, Angela D'Angelo, Jamie W. Chang, Mitchell H. Rosner, Claudio Ronco

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: